Glenmark Pharmaceuticals
GLENMARK.NS
$15.99
Share price
0.13%
Change (1 day)
27.52%
Change (1 year)
Categories
Glenmark Pharmaceuticals (GLENMARK.NS) - P/B ratio
P/B ratio as of April 2025 : 4.48
According to Glenmark Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 2.93505.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Glenmark Pharmaceuticals - P/B ratio (from 2012 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | 5.20 | 109.67% |
| 2023-12-31 | 2.48 | 108.95% |
| 2022-12-31 | 1.19 | -28.3% |
| 2021-12-31 | 1.65 | -23.57% |
| 2020-12-31 | 2.16 | 31.6% |
| 2019-12-31 | 1.64 | -52.09% |
| 2018-12-31 | 3.43 | 9.26% |
| 2017-12-31 | 3.14 | -39.85% |
| 2016-12-31 | 5.22 | -17.17% |
| 2015-12-31 | 6.30 | -2.62% |
| 2014-12-31 | 6.47 | 26.71% |
| 2013-12-31 | 5.11 | -6.57% |
| 2012-12-31 | 5.47 |